Predicting the rate of cognitive decline in aging and early Alzheimer disease
- PMID: 15249619
- DOI: 10.1212/01.wnl.0000132520.69612.ab
Predicting the rate of cognitive decline in aging and early Alzheimer disease
Abstract
Objectives: To determine prognostic factors affecting the course of Alzheimer disease (AD) and to determine the role of region-specific brain volumes as predictors of cognitive decline.
Methods: Longitudinal data from 166 normal elderly individuals and 59 early AD patients were analyzed. Brain volumes were extracted from MRI scans using semiautomated recursive segmentation methods. Prognostic factors were considered significant if they had a significant effect on the rate of cognitive decline.
Results: In multivariate analysis, higher Clinical Dementia Rating Scale (CDR) score at entry was a significant prognostic factor for an increased rate of cognitive decline. Significant prognostic factors within the baseline CDR = 0 group were base rate of progression and percent total high signal intensity (HSI), percent ventricular, and percent CSF volumes. Base rate of progression, family history, and percent ventricular volume were significant prognostic factors within the CDR = 0.5 group and APOE had a marginally significant effect on the rate of cognitive decline in the CDR = 1 group.
Conclusions: Percent total HSI, ventricular, and total CSF volume measures can independently predict the rate of cognitive decline and improve the predictive power of statistical models that use only clinical data. Brain volumetric measures from MRI can be used to estimate the rate of cognitive decline even among normal elderly individuals and thus may aid in the prediction of time of onset of disease.
Similar articles
-
Natural history of cognitive decline in the old old.Neurology. 2003 May 13;60(9):1489-94. doi: 10.1212/01.wnl.0000063317.44167.5c. Neurology. 2003. PMID: 12743237
-
Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.JAMA Neurol. 2016 May 1;73(5):561-71. doi: 10.1001/jamaneurol.2016.0086. JAMA Neurol. 2016. PMID: 27018940 Free PMC article.
-
Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.Neurology. 2008 Jan 15;70(3):191-9. doi: 10.1212/01.wnl.0000287091.57376.65. Neurology. 2008. PMID: 18195264 Clinical Trial.
-
Cognitive decline in schizophrenics with Alzheimer's disease: a mini-review of neuropsychological and neuropathological studies.Prog Neuropsychopharmacol Biol Psychiatry. 2001 Oct;25(7):1359-66. doi: 10.1016/s0278-5846(01)00191-9. Prog Neuropsychopharmacol Biol Psychiatry. 2001. PMID: 11513351 Review.
-
Cognitive and neurobiologic markers of early Alzheimer disease.Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13547-51. doi: 10.1073/pnas.93.24.13547. Proc Natl Acad Sci U S A. 1996. PMID: 8942970 Free PMC article. Review.
Cited by
-
Association of Essential Tremor With Dementia and Affective Disorders: A Meta-Analysis.Front Neurol. 2022 Mar 17;13:842732. doi: 10.3389/fneur.2022.842732. eCollection 2022. Front Neurol. 2022. PMID: 35370922 Free PMC article.
-
Cognitive decline, sensory impairment, and the use of audio-visual aids by long-term care facility residents.BMC Geriatr. 2022 Mar 16;22(1):216. doi: 10.1186/s12877-022-02895-x. BMC Geriatr. 2022. PMID: 35296238 Free PMC article.
-
Genome-wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways.Alzheimers Dement. 2020 Aug;16(8):1134-1145. doi: 10.1002/alz.12106. Epub 2020 Jun 23. Alzheimers Dement. 2020. PMID: 32573913 Free PMC article.
-
Cerebrospinal Fluid and MRI Biomarkers in Neurodegenerative Diseases: A Retrospective Memory Clinic-Based Study.J Alzheimers Dis. 2020;75(3):751-765. doi: 10.3233/JAD-200175. J Alzheimers Dis. 2020. PMID: 32310181 Free PMC article.
-
Alzheimer's and Hyperglycemia: Role of the Insulin Signaling Pathway and GSK-3 Inhibition in Paving a Path to Dementia.Cureus. 2020 Feb 5;12(2):e6885. doi: 10.7759/cureus.6885. Cureus. 2020. PMID: 32190448 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous